Gene: STK32B
Official Full Name: serine/threonine kinase 32Bprovided by HGNC
Gene Summary: This gene encodes a serine-threonine protein kinase. Serine-threonine kinases transfer phosphate molecules to the oxygen atoms of serine and threonine. A genomic deletion affecting this gene has been associated with Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13684 | STK32B Knockout cell line (HeLa) | Human | STK32B | 1:3~1:6 | Negative | Online Inquiry |
KO13685 | STK32B Knockout cell line (A549) | Human | STK32B | 1:3~1:4 | Negative | Online Inquiry |
STK32B Gene Knockout Cell Lines are precisely engineered cellular models that lack the STK32B gene, a vital component implicated in various biological processes, including cell proliferation and apoptosis. These knockout cell lines provide researchers with an invaluable tool for elucidating the functional role of the STK32B gene in cellular mechanisms and disease states. By creating a complete absence of this gene, scientists can investigate its pathways and interactions, providing clarity on its implications in conditions such as cancer and metabolic disorders.
The key function of these cell lines lies in their ability to enable targeted studies of gene function, enabling researchers to analyze phenotypic variations that arise from the absence of STK32B. The mechanistic insights gained from experiments utilizing STK32B knockout models can shine light on cellular pathways, helping to elucidate the biological underpinnings of diseases where STK32B is involved. This makes the lines particularly valuable for both basic research and translational studies, where understanding gene function is critical for developing novel therapeutics.
STK32B Gene Knockout Cell Lines stand out from alternative models due to their robust validation, reproducibility, and the specific targeting of the STK32B gene, making them an ideal choice for researchers who require high specificity and ease of use in their experiments. Unlike other less precise knockout models, our cell lines assure a complete and systemic loss of gene function, enabling clearer interpretations of experimental outcomes.
The value of these cell lines extends to both academia and the pharmaceutical industry, providing a reliable platform for drug discovery, genetic studies, and therapeutic development. Researchers and clinicians can leverage these models to accelerate their findings and applications towards groundbreaking therapies or interventions.
Our company prides itself on its commitment to developing high-quality, scientifically validated biological products. With extensive expertise in genetic engineering and a portfolio that includes a diverse range of knockout models, we empower researchers and clinicians with the tools they need to drive innovation in their respective fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.